Edition:
United Kingdom

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

9.08CNY
23 Apr 2019
Change (% chg)

¥0.01 (+0.11%)
Prev Close
¥9.07
Open
¥9.10
Day's High
¥9.24
Day's Low
¥9.00
Volume
62,166,395
Avg. Vol
103,750,905
52-wk High
¥11.28
52-wk Low
¥5.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 1,817.82 0.082
Jun '18 1,794.13 0.105
Mar '18 1,782.26 0.100
FY 2017 Dec '17 1,510.51 0.041
Sep '17 1,443.13 0.089
Jun '17 1,243.59 0.078
Mar '17 1,096.73 0.075
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Year Ending Dec-19 1 0.35 0.35 0.35 --
Sales and Profit Figures in China Yuan Renminbi (CNY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 27.62 62.58 62.94
P/E High - Last 5 Yrs. 47.71 49.40 56.44
P/E Low - Last 5 Yrs. 22.12 27.73 28.76
Beta 0.92 0.93 0.93
Price to Sales (TTM) 3.50 7.59 9.69
Price to Book (MRQ) 4.08 3.95 4.53
Price to Tangible Book (MRQ) 5.31 7.41 8.07
Price to Cash Flow (TTM) -- 43.88 43.55
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield 1.65 1.70 1.54
Dividend Yield - 5 Year Avg -- 0.71 0.70
Dividend 5 Year Growth Rate 26.09 2.09 2.98
Payout Ratio(TTM) 45.96 21.68 21.89

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 25.96 7.63 9.11
Sales (TTM) vs TTM 1 Yr. Ago 31.11 4.62 8.34
Sales - 5 Yr. Growth Rate 14.13 9.88 11.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.74 140.32 112.52
EPS (TTM) vs TTM 1 Yr. Ago 37.86 -- --
EPS - 5 Yr. Growth Rate 11.18 5.17 6.94
Capital Spending - 5 Yr. Growth Rate 4.01 6.58 7.63

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.12 2.67 2.67
Current Ratio (MRQ) 1.40 3.68 3.63
LT Debt to Equity (MRQ) 21.04 12.60 13.38
Total Debt to Equity (MRQ) 42.43 15.29 17.12
Interest Coverage (TTM) 8.76 30.57 27.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 73.83 51.68 50.33
Gross Margin - 5 Yr. Avg. 60.57 49.82 50.77
EBITD Margin (TTM) 17.17 -- --
EBITD - 5 Yr. Avg 17.83 17.16 15.75
Operating Margin (TTM) 15.58 3.39 -2.12
Operating Margin - 5 Yr. Avg. 13.93 13.47 11.07
Pre-Tax Margin (TTM) 15.44 2.49 -2.97
Pre-Tax Margin - 5 Yr. Avg. 14.90 20.39 16.81
Net Profit Margin (TTM) 12.89 -1.31 -6.92
Net Profit Margin - 5 Yr. Avg. 12.20 15.22 11.75
Effective Tax Rate (TTM) 16.56 22.79 22.89
Effective Tax Rate - 5 Yr. Avg. 18.17 23.63 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 787,041 899,601,152 767,389,378
Net Income/Employee (TTM) 101,425 103,597,006 88,365,779
Receivable Turnover (TTM) 5.47 5.42 5.22
Inventory Turnover (TTM) 1.99 2.62 3.64
Asset Turnover (TTM) 0.72 0.84 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 9.27 9.91 9.51
Return on Assets - 5 Yr. Avg. 7.88 11.00 10.45
Return on Investment (TTM) 13.51 12.13 11.75
Return on Investment - 5 Yr. Avg. 12.55 14.03 13.34
Return on Equity (TTM) 16.52 13.07 12.58
Return on Equity - 5 Yr. Avg. 14.59 15.27 14.82
  1 Year 3 Year 5 Year
Sales % -12.07 13.91 14.13
EPS (TTM) % 59.39 1.53 11.18
Dividend % 25.00 31.03 26.09
Note: Units in Millions of US Dollars

Performance for Zhejiang CONBA Pharmaceutical Co Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.20%
# of Holders: 26
Total Shares Held: 191,955,268
3 Mo. Net Change: 63,039
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 4
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.